Comparison of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold-Plus in the Diagnosis of <i>Mycobacterium tuberculosis</i> Infections in Immunocompromised Patients: a Real-World Study
Yuzhen Xu, Qingluan Yang, Jingyu Zhou, Feiran Zhou, Yufan Hezhang, Yan Gao, Lingyun Shao, Jichan Shi, Qiaoling Ruan, Wenhong Zhang
Abstract
This study evaluated the performance of QFT-GIT and QFT-Plus in the diagnosis of M. tuberculosis infection in immunocompromised patients and found that QFT-Plus may detect more LTBI than QFT-GIT does in patients receiving long-term immunosuppressant therapy. We believe that our study makes a significant contribution to the literature because it highlights the different diagnostic accuracies of QFT-GIT and QFT-Plus in different subpopulations of immunocompromised and immunocompetent patients. Selecting a test with better performance, particularly in patients with a high risk of developing active TB, may assist the health sector in better managing TB. Furthermore, we believe that this study will be of significance to the diagnosis of LTBI.